X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2128) 2128
Book Review (757) 757
Publication (120) 120
Book Chapter (8) 8
Conference Proceeding (5) 5
Magazine Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1885) 1885
humans (1850) 1850
diabetes mellitus, type 2 - drug therapy (1380) 1380
dipeptidyl-peptidase iv inhibitors - therapeutic use (1087) 1087
male (903) 903
hypoglycemic agents - therapeutic use (848) 848
type 2 diabetes (846) 846
female (766) 766
dipeptidyl-peptidase iv inhibitors - adverse effects (730) 730
endocrinology & metabolism (710) 710
middle aged (657) 657
diabetes (632) 632
hypoglycemic agents - adverse effects (552) 552
aged (531) 531
animals (482) 482
treatment outcome (482) 482
glucagon-like peptide-1 (458) 458
pharmacology & pharmacy (452) 452
sitagliptin (435) 435
diabetes mellitus, type 2 - blood (412) 412
adamantane - analogs & derivatives (387) 387
double-blind (384) 384
adult (380) 380
glucose (375) 375
metformin (365) 365
dipeptidyl-peptidase iv inhibitors - administration & dosage (359) 359
hypoglycemic agents (353) 353
dipeptidyl-peptidase iv inhibitors - pharmacology (347) 347
glycemic control (346) 346
dipeptidyl peptidase-4 inhibitor (343) 343
drug therapy, combination (330) 330
hypoglycemic agents - administration & dosage (318) 318
risk factors (308) 308
blood glucose - drug effects (302) 302
blood glucose - metabolism (296) 296
insulin (279) 279
diabetes mellitus (275) 275
vildagliptin (275) 275
care and treatment (267) 267
dipeptidyl peptidase 4 - metabolism (261) 261
safety (259) 259
analysis (258) 258
metformin - therapeutic use (255) 255
sitagliptin phosphate (253) 253
adamantane - therapeutic use (248) 248
drug therapy (247) 247
type 2 diabetes mellitus (247) 247
type-2 diabetes-mellitus (245) 245
diabetes therapy (238) 238
glycated hemoglobin a - metabolism (235) 235
diabetes mellitus, type 2 - complications (234) 234
double-blind method (233) 233
efficacy (225) 225
dipeptidyl peptidase-4 inhibitors (222) 222
internal medicine (219) 219
beta-cell function (218) 218
hypoglycemic agents - pharmacology (213) 213
medicine, general & internal (212) 212
adamantane - adverse effects (201) 201
dpp-4 inhibitor (201) 201
research (201) 201
improves glycemic control (195) 195
dextrose (192) 192
clinical trials (191) 191
hypoglycemia - chemically induced (187) 187
linagliptin (187) 187
abridged index medicus (178) 178
therapy (177) 177
hypoglycemia (171) 171
glucagon (170) 170
mellitus (169) 169
triazoles - therapeutic use (169) 169
pyrazines - therapeutic use (168) 168
risk (165) 165
sulfonylurea compounds - therapeutic use (161) 161
diabetes mellitus, type 2 - metabolism (160) 160
pyrrolidines - therapeutic use (158) 158
medicine & public health (157) 157
dosage and administration (155) 155
rats (155) 155
peptidase (154) 154
randomized controlled trials as topic (154) 154
dpp-4 inhibitors (153) 153
peptides (153) 153
health aspects (151) 151
nitriles - therapeutic use (151) 151
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (148) 148
hyperglycemia (147) 147
cardiac & cardiovascular systems (146) 146
dipeptidyl-peptidase iv inhibitors (146) 146
mice (145) 145
glp-1 (144) 144
incretins - therapeutic use (143) 143
drug-naive patients (142) 142
pharmacokinetics (140) 140
diabetes mellitus, type 2 - physiopathology (137) 137
time factors (137) 137
saxagliptin (133) 133
mortality (126) 126
glycosylated hemoglobin (124) 124
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2072) 2072
French (17) 17
German (15) 15
Spanish (15) 15
Japanese (7) 7
Hungarian (3) 3
Russian (3) 3
Czech (2) 2
Danish (1) 1
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 1994, Volume 56, Issue 6, pp. 407 - 420
Thalidomide (Thd) is capable of down-regulating the CD26 receptor on CD4 lymphocytes after treatment of healthy volunteers. Similar effects are observed when... 
lymphocytes | thalidomide | marmosets | humans | CD26 receptor | TAT PROTEIN | MEDICINE, RESEARCH & EXPERIMENTAL | HUMANS | AIDS | THALIDOMIDE | ACTIVATION ANTIGEN | HUMAN-IMMUNODEFICIENCY-VIRUS | CD26 RECEPTOR | CD4 | INHIBITION | MARMOSETS | BIOLOGY | PHARMACOLOGY & PHARMACY | TYPE-1 | EXPRESSION | LYMPHOCYTES | DIPEPTIDYL PEPTIDASE-IV
Journal Article
Psychiatry Research, ISSN 0165-1781, 1995, Volume 58, Issue 3, pp. 217 - 225
Journal Article